DUBLIN, Ireland, Jan. 22, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that Sev Melkonian has joined the ...
Some results have been hidden because they may be inaccessible to you